Tech Company M&A Transactions
AbVitro Acquisition
AbVitro was bought by Juno Therapeutics. The deal occurred on 1/12/2016. The parties disclosed the acquisition price to be $125 million.
Transaction Overview
Company Name
Acquired By
Announced On
1/12/2016
Transaction Type
M&A
Amount
$125,000,000
M&A Terms
Juno Therapeutics has acquired AbVitro of Boston for approximately $78 million in cash and almost 1.3 million shares of its stock, the company said.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
27 Drydock Ave 6th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Overview
AbVitro is a venture backed next-generation antibody discovery focused on discovery of human-derived antibodies and biomarkers that are otherwise intractable using existing approaches.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Ostrove
Chief Scientific Officer
Francois Vigneault
Browse more venture capital transactions:
Prev: 1/12/2016: higi venture capital transaction
Next: 1/12/2016: Syapse venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs